Hologic Inc.
Hologic, Inc. Appoints Martin Madaus to Board of Directors
Summary
On December 6, 2024, Hologic, Inc. announced the appointment of Martin Madaus to its Board of Directors, effective immediately. Dr. Madaus, a seasoned executive with over 30 years of experience in the diagnostics and life sciences industry, will also serve on the Compensation and Nominating and Corporate Governance Committees. This appointment increases the Board size from nine to ten directors. Dr. Madaus currently serves as an Operating Executive at the Carlyle Group and has previously held leadership roles at Ortho Clinical Diagnostics and Millipore Corporation.
Profitelligence Alerts
Get alerts for HOLX
Be first to know when Hologic Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Official SEC Documents
Advertisement